1. Home
  2. IRWD vs YSXT Comparison

IRWD vs YSXT Comparison

Compare IRWD & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • YSXT
  • Stock Information
  • Founded
  • IRWD 1998
  • YSXT 2011
  • Country
  • IRWD United States
  • YSXT China
  • Employees
  • IRWD N/A
  • YSXT N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • YSXT Automotive Aftermarket
  • Sector
  • IRWD Health Care
  • YSXT Consumer Discretionary
  • Exchange
  • IRWD Nasdaq
  • YSXT Nasdaq
  • Market Cap
  • IRWD 97.4M
  • YSXT 110.4M
  • IPO Year
  • IRWD 2010
  • YSXT 2024
  • Fundamental
  • Price
  • IRWD $0.71
  • YSXT $5.38
  • Analyst Decision
  • IRWD Buy
  • YSXT
  • Analyst Count
  • IRWD 5
  • YSXT 0
  • Target Price
  • IRWD $4.94
  • YSXT N/A
  • AVG Volume (30 Days)
  • IRWD 3.2M
  • YSXT 176.0K
  • Earning Date
  • IRWD 08-07-2025
  • YSXT 08-15-2025
  • Dividend Yield
  • IRWD N/A
  • YSXT N/A
  • EPS Growth
  • IRWD N/A
  • YSXT N/A
  • EPS
  • IRWD N/A
  • YSXT 0.18
  • Revenue
  • IRWD $317,676,000.00
  • YSXT $66,143,276.00
  • Revenue This Year
  • IRWD N/A
  • YSXT N/A
  • Revenue Next Year
  • IRWD N/A
  • YSXT N/A
  • P/E Ratio
  • IRWD N/A
  • YSXT $30.75
  • Revenue Growth
  • IRWD N/A
  • YSXT 21.23
  • 52 Week Low
  • IRWD $0.53
  • YSXT $2.06
  • 52 Week High
  • IRWD $7.11
  • YSXT $9.96
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 51.76
  • YSXT N/A
  • Support Level
  • IRWD $0.62
  • YSXT N/A
  • Resistance Level
  • IRWD $0.74
  • YSXT N/A
  • Average True Range (ATR)
  • IRWD 0.08
  • YSXT 0.00
  • MACD
  • IRWD 0.02
  • YSXT 0.00
  • Stochastic Oscillator
  • IRWD 52.24
  • YSXT 0.00

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: